Common Stock, Shares, Outstanding of MAXCYTE, INC. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
MAXCYTE, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • MAXCYTE, INC. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 106,644,343, a 1.3% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

MAXCYTE, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 106,644,343 +1,343,963 +1.3% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 106,592,139 +1,768,015 +1.7% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 106,313,718 +1,908,607 +1.8% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 105,711,093 +1,749,423 +1.7% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 105,300,380 +1,751,437 +1.7% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 104,824,124 +1,689,539 +1.6% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 104,405,111 +1,500,366 +1.5% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 103,961,670 +1,563,757 +1.5% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 103,548,943 +1,644,630 +1.6% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 103,134,585 +1,473,297 +1.4% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 102,904,745 +1,394,853 +1.4% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 102,397,913 +1,195,208 +1.2% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 101,904,313 +1,470,281 +1.5% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 101,661,288 +16,941,943 +20% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 101,509,892 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 101,202,705 +23,820,232 +31% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 100,434,032 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 84,719,345 30 Jun 2021 10-Q 13 Sep 2021 2021 Q2
Q4 2020 77,382,473 31 Dec 2020 10-K 22 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.